Breaking News

WuXi PharmaTech Breaks Ground for New Changzhou Campus

Will provide early stage preclinical to commercial production

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

WuXi PharmaTech’s manufacturing subsidiary, Syn-The-All (STA) Pharmaceuticals Co., Ltd., began construction of a new R&D and cGMP manufacturing site in Changzhou, China.    The new campus will be constructed in phases and include both research manufacturing and commercial manufacturing facilities. Phase one will double the company’s current manufacturing capacity and is expected to be operational by 4Q15. Once the entire project is complete, the site will triple current capacity and em...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters